july

Fellaz Launches Decentralized Entertainment Protocol Stack | Massive Giveaway Live: Win $3,000 Beta Access + Over 2,000 USDT

SINGAPORE, July 4, 2025 /PRNewswire/ -- Web3 entertainment protocol Fellaz has officially launched its decentralized entertainment stack, composed of three…

4 months ago

Shah Rukh Khan to Grace the Grand Opening of City of Dreams Sri Lanka

MUMBAI, India, July 4, 2025 /PRNewswire/ -- The undisputed King of Bollywood, Shah Rukh Khan, is set to make a spectacular…

4 months ago

Good Game, World’s First As-live Global Gaming Reality Show announced

NEW YORK, July 2, 2025 /PRNewswire/ -- Good Game Group Inc. has announced the launch of Good Game, the world's First 'As-live'…

4 months ago

HH Global assembles leadership team to establish Nuevo as global creative ecosystem

LONDON, July 2, 2025 /PRNewswire/ -- HH Global, the world's leading responsible marketing activation partner, today announces a quartet of…

4 months ago

Bybit TradFi x Crypto Report: Regulatory Tailwinds Drive Coinbase Outperformance Despite Premium Valuation

DUBAI, UAE, July 4, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, has released a new…

4 months ago

Vantage Shines at Money Expo Colombia 2025 with Industry Recognition and Dynamic Engagement

PORT VILA, Vanuatu, July 4, 2025 /PRNewswire/ -- Vantage Markets wrapped up a highly successful showing at Money Expo Colombia…

4 months ago

ASYAD GROUP SUCCESSFULLY COMPLETES COMPLEX AIR CARGO OPERATION TO MAJOR ASIAN ECONOMIC HUB

MUSCAT, Oman, July 3, 2025 /PRNewswire/ -- Asyad Group, Oman's global integrated logistics provider, has successfully executed a high-priority air…

4 months ago

Wynn Macau and Wynn Palace Will Host Asia’s 50 Best Bars 2025 Awards This July

Wynn announces its curated events program for Asia's 50 Best Bars 2025, bringing together the world's leading talents in a…

4 months ago

Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessas Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist

July 04, 2025 03:00 ET  | Source: Nxera Pharma Tokyo, Japan and Cambridge, UK, 4 July 2025 – Nxera Pharma…

4 months ago

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer

PRESS RELEASE MASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3 TRIAL IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER, WITH BIOMARKER-DRIVEN…

4 months ago